Qiagen (QGEN) Reports In-Line Q1 EPS; Reaffirms

Go back to Qiagen (QGEN) Reports In-Line Q1 EPS; Reaffirms

QIAGEN Reports Results for First Quarter 2015

May 5, 2015 4:00 PM EDT

VENLO, The Netherlands, May 5, 2015 /PRNewswire/ --

Q1 2015 results: Adjusted net sales of $298.7 million (+2% CER); adjusted operating income of $67.4 million; and adjusted EPS of $0.22 ($0.24 CER)  Adjusted net sales rise 8% CER excluding reduced HPV sales in U.S.   Investments transforming QIAGEN and strengthening expansion   Free cash flow rises 40% to $39.7 million  QIAGEN reaffirms expectations for higher 2015 CER adjusted net sales and earnings; expect adverse impact on reported results from currency movements 

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard:... More